QuidelOrtho (QDEL) EPS (Weighted Average and Diluted) (2021 - 2024)

QuidelOrtho has disclosed EPS (Weighted Average and Diluted) across 4 years of filings, most recently posting -$25.5 for Q1 2024.

• EPS (Weighted Average and Diluted) for Q1 2024 came in at -$25.5, down 3593.15% year-over-year; the trailing twelve-month figure through Dec 2024 was -$25.39 (down 154.63% YoY), and the FY2024 annual result was -$30.54, down 20260.0% from the prior year.
• EPS (Weighted Average and Diluted) came in at -$25.5 for Q1 2024 at QuidelOrtho, down from -$9.71 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $11.31 in Q2 2022 to a low of -$25.5 in Q1 2024.
• The 4-year median for EPS (Weighted Average and Diluted) is $0.28 (2022), against an average of -$1.65.
• Across the five-year window, EPS (Weighted Average and Diluted) retreated 20.0% in 2022 and tumbled 5968.75% in 2023, its largest moves.
• QuidelOrtho's EPS (Weighted Average and Diluted) stood at $5.08 in 2021, then sank by 94.49% to $0.28 in 2022, then plunged by 3567.86% to -$9.71 in 2023, then slumped by 162.62% to -$25.5 in 2024.
• The last three EPS (Weighted Average and Diluted) figures came in at -$25.5 (Q1 2024), -$9.71 (Q4 2023), and -$0.19 (Q4 2023), per Business Quant data.